Sigachi Industries Limited (SIGACHI) - Net Assets
Based on the latest financial reports, Sigachi Industries Limited (SIGACHI) has net assets worth Rs5.19 Billion INR (≈ $56.15 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs8.51 Billion ≈ $92.00 Million USD) and total liabilities (Rs3.32 Billion ≈ $35.85 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SIGACHI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs5.19 Billion |
| % of Total Assets | 61.03% |
| Annual Growth Rate | 56.77% |
| 5-Year Change | 550.84% |
| 10-Year Change | N/A |
| Growth Volatility | 36.83 |
Sigachi Industries Limited - Net Assets Trend (2018–2025)
This chart illustrates how Sigachi Industries Limited's net assets have evolved over time, based on quarterly financial data. Also explore Sigachi Industries Limited (SIGACHI) total assets for the complete picture of this company's asset base.
Annual Net Assets for Sigachi Industries Limited (2018–2025)
The table below shows the annual net assets of Sigachi Industries Limited from 2018 to 2025. For live valuation and market cap data, see Sigachi Industries Limited (SIGACHI) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs6.13 Billion ≈ $66.30 Million |
+39.01% |
| 2024-03-31 | Rs4.41 Billion ≈ $47.70 Million |
+64.34% |
| 2023-03-31 | Rs2.68 Billion ≈ $29.02 Million |
+17.82% |
| 2022-03-31 | Rs2.28 Billion ≈ $24.63 Million |
+141.81% |
| 2021-03-31 | Rs941.99 Million ≈ $10.19 Million |
+45.85% |
| 2020-03-31 | Rs645.85 Million ≈ $6.98 Million |
+43.90% |
| 2019-03-31 | Rs448.83 Million ≈ $4.85 Million |
+70.39% |
| 2018-03-31 | Rs263.41 Million ≈ $2.85 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Sigachi Industries Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1281.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs2.43 Billion | 40.48% |
| Common Stock | Rs382.12 Million | 6.36% |
| Other Comprehensive Income | Rs490.03 Million | 8.16% |
| Other Components | Rs2.70 Billion | 45.01% |
| Total Equity | Rs6.01 Billion | 100.00% |
Sigachi Industries Limited Competitors by Market Cap
The table below lists competitors of Sigachi Industries Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Fifth District Bancorp, Inc. Common Stock
NASDAQ:FDSB
|
$83.48 Million |
|
Health In Tech, Inc. Class A Common Stock
NASDAQ:HIT
|
$83.48 Million |
|
Dae Young Pkg
KO:014160
|
$83.50 Million |
|
Nobleoak Life Ltd
AU:NOL
|
$83.52 Million |
|
Byuksan Corp
KO:007210
|
$83.46 Million |
|
FM Global Logistics Holdings Bhd
KLSE:7210
|
$83.42 Million |
|
JITF Infralogistics Limited
NSE:JITFINFRA
|
$83.39 Million |
|
WTK Holdings Bhd
KLSE:4243
|
$83.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sigachi Industries Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,296,374,000 to 6,008,496,000, a change of 1,712,122,000 (39.9%).
- Net income of 695,631,000 contributed positively to equity growth.
- Dividend payments of 32,819,000 reduced retained earnings.
- New share issuances of 1,055,523,000 increased equity.
- Other comprehensive income decreased equity by 426,496,001.
- Other factors increased equity by 420,283,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs695.63 Million | +11.58% |
| Dividends Paid | Rs32.82 Million | -0.55% |
| Share Issuances | Rs1.06 Billion | +17.57% |
| Other Comprehensive Income | Rs-426.50 Million | -7.1% |
| Other Changes | Rs420.28 Million | +6.99% |
| Total Change | Rs- | 39.85% |
Book Value vs Market Value Analysis
This analysis compares Sigachi Industries Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.38x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 23.58x to 1.38x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-03-31 | Rs0.86 | Rs20.20 | x |
| 2019-03-31 | Rs1.46 | Rs20.20 | x |
| 2020-03-31 | Rs2.10 | Rs20.20 | x |
| 2021-03-31 | Rs3.06 | Rs20.20 | x |
| 2022-03-31 | Rs7.41 | Rs20.20 | x |
| 2023-03-31 | Rs8.73 | Rs20.20 | x |
| 2024-03-31 | Rs11.54 | Rs20.20 | x |
| 2025-03-31 | Rs14.63 | Rs20.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sigachi Industries Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.58%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.25%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 1.41x
- Recent ROE (11.58%) is below the historical average (23.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 26.28% | 6.74% | 1.42x | 2.74x | Rs42.88 Million |
| 2019 | 42.36% | 14.74% | 1.41x | 2.04x | Rs145.24 Million |
| 2020 | 31.46% | 14.61% | 1.27x | 1.69x | Rs138.57 Million |
| 2021 | 32.12% | 15.70% | 1.44x | 1.42x | Rs208.40 Million |
| 2022 | 17.58% | 16.00% | 0.87x | 1.26x | Rs172.59 Million |
| 2023 | 16.22% | 14.41% | 0.81x | 1.39x | Rs167.00 Million |
| 2024 | 13.31% | 14.33% | 0.57x | 1.62x | Rs142.16 Million |
| 2025 | 11.58% | 14.25% | 0.58x | 1.41x | Rs94.78 Million |
Industry Comparison
This section compares Sigachi Industries Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $23,713,303,062
- Average return on equity (ROE) among peers: 8.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sigachi Industries Limited (SIGACHI) | Rs5.19 Billion | 26.28% | 0.64x | $83.48 Million |
| Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) | $988.60 Million | 6.59% | 1.36x | $27.93 Million |
| Aarti Drugs Limited (AARTIDRUGS) | $6.52 Billion | 21.67% | 1.42x | $371.43 Million |
| Aarti Pharmalabs Limited (AARTIPHARM) | $19.90 Billion | 13.69% | 0.46x | $725.68 Million |
| Abbott India Limited (ABBOTINDIA) | $36.99 Billion | 32.48% | 0.40x | $5.85 Billion |
| Ajanta Pharma Limited (AJANTPHARM) | $1.16 Billion | 12.69% | 1.32x | $3.81 Billion |
| Akums Drugs and Pharmaceutical (AKUMS) | $6.25 Billion | -40.39% | 3.91x | $906.19 Million |
| Alkem Laboratories Limited (ALKEM) | $88.47 Billion | 18.60% | 0.59x | $6.98 Billion |
| Amrutanjan Health Care Limited (AMRUTANJAN) | $1.46 Billion | 16.82% | 0.29x | $178.52 Million |
| Alembic Pharmaceuticals Limited (APLLTD) | $51.90 Billion | 11.24% | 0.50x | $1.60 Billion |
| Aurobindo Pharma Limited (AUROPHARMA) | $23.50 Billion | -5.26% | 1.65x | $8.73 Billion |
About Sigachi Industries Limited
Sigachi Industries Limited manufactures and sells microcrystalline cellulose and cellulose powder in India. The company offers cellulose-based products under the HiCel, AceCel, CoatCel, GloCel, and BARETab names; and various chemicals, including colloidal silicon dioxide, carboxy cellulose sodium and mannitol, etc. to active pharmaceutical ingredients, food and nutrition, cosmetic, and chemical i… Read more